57894-505-05 |
57894-505 |
HUMAN PRESCRIPTION DRUG |
Darzalex IV |
Daratumumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20211015 |
N/A |
BLA |
BLA761036 |
Janssen Biotech, Inc. |
DARATUMUMAB |
100 mg/5mL |
1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-05) / 5 mL in 1 VIAL, SINGLE-DOSE |
57894-505-20 |
57894-505 |
HUMAN PRESCRIPTION DRUG |
Darzalex IV |
Daratumumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20211015 |
N/A |
BLA |
BLA761036 |
Janssen Biotech, Inc. |
DARATUMUMAB |
100 mg/5mL |
1 VIAL, SINGLE-DOSE in 1 BOX (57894-505-20) / 20 mL in 1 VIAL, SINGLE-DOSE |
57894-502-05 |
57894-502 |
HUMAN PRESCRIPTION DRUG |
DARZALEX |
Daratumumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20151116 |
20261031 |
BLA |
BLA761036 |
Janssen Biotech, Inc. |
DARATUMUMAB |
100 mg/5mL |
1 VIAL in 1 CARTON (57894-502-05) / 5 mL in 1 VIAL |
57894-502-20 |
57894-502 |
HUMAN PRESCRIPTION DRUG |
DARZALEX |
Daratumumab |
INJECTION, SOLUTION, CONCENTRATE |
INTRAVENOUS |
20151116 |
20261130 |
BLA |
BLA761036 |
Janssen Biotech, Inc. |
DARATUMUMAB |
100 mg/5mL |
1 VIAL in 1 CARTON (57894-502-20) / 20 mL in 1 VIAL |